The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
- PMID: 37250870
- PMCID: PMC10213853
- DOI: 10.1016/j.jceh.2022.12.005
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States
Abstract
Background: Nonalcoholic steatohepatitis (NASH) is a cause of chronic liver disease.
Aim: Model the burden of NASH in the United States according to obesity.
Methods: The discrete-time Markov model comprised adult NASH subjects moving through 9 health states and 3 absorbing death states (liver, cardiac, and other deaths) with 1-year cycles and a 20-year horizon. Given that reliable natural history data for NASH are not available, transition probabilities were estimated from the literature and population-based data. These rates were disaggregated to determine age-obesity group rates by applying estimated age-obesity patterns. The model considers 2019 prevalent NASH cases and new incident NASH cases (2020-2039), assuming that recent trends will continue. Annual per-patient costs by health state were based on published data. Costs were standardized to 2019 US dollars and inflated by 3% annually.
Results: NASH cases in the United States are forecasted to increase by +82.6%, from 11.61 million (2020) to 19.53 million (2039). During the same period, cases of advanced liver disease increased +77.9%, from 1.51 million to 2.67 million, while its proportion remained stable (13.46%-13.05%). Similar patterns were observed in both obese and non-obese NASH. Among NASH, 18.71 million overall deaths, 6.72 million cardiac-specific deaths, and 1.71 million liver-specific deaths were observed by 2039. During this period, the projected cumulative direct healthcare costs were $1208.47 billion (obese NASH) and $453.88 billion (non-obese NASH). By 2039, the projected NASH attributable healthcare cost per patient increased from $3636 to $6968.
Conclusions: There is a substantial and growing clinical and economic burden of NASH in the United States.
Keywords: GBD; NAFLD; NHANES; age group; obesity.
© 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.
Figures





References
-
- World Health Organization (WHO) Facts on obesity. https://www.who.int/health-topics/obesity#tab=tab_1 Obtained from the world wide web at:
-
- Center for Disease Control (CDC) Facts on obesity. https://www.cdc.gov/obesity/adult/defining.html Obtained from the world wide web at:
-
- Center for Disease Control (CDC) Facts on childhood obesity. https://www.cdc.gov/vitalsigns/childhoodobesity/index.html Obtained from the world wide web at:
LinkOut - more resources
Full Text Sources